(PRESS RELEASE) HELSINKI, 4-Jan-2023 — /EuropaWire/ — Outokumpu (HEL: OUT1V), the largest producer of stainless steel in Europe, has announced the repurchase of 100,513 own shares as part of its share buyback program. The transactions (ISIN FI0009002422), carried out on January 3, 2023, are as follows:
Trading venue | Number of shares | Weighted average price / share, EUR* | Total cost, EUR* |
CEUX | 36,207 | 4.8508 | 175,633.39 |
XHEL | 56,370 | 4.857 | 273,788.16 |
AQEU | 6,972 | 4.8582 | 33,871.59 |
TQEX | 964 | 4.859 | 4,684.08 |
Total: | 100,513 | 4.85 | 487,977.21 |
* Rounded to two decimals
Outokumpu announced a share buyback program of a maximum of 20 million shares on November 3, 2022. The Board of Directors approved a share buyback program of up to EUR 100 million under the authorization of the Annual General Meeting. The program will end no later than on March 24, 2023.
After the disclosed transactions, Outokumpu holds 13,610,761 treasury shares.
Details of transactions are included as an appendix to this announcement.
For more information:
Investors: Linda Häkkilä, Head of Investor Relations, tel. +358 400 719 669
Media: Päivi Allenius, VP – Communications and Brand, tel. +358 40 753 7374
Media desk, tel. +358 40 351 9840, e-mail media@outokumpu.com
SOURCE: Outokumpu Oyj
(IN BRIEF) Eurex, on April 29, 2024, introduced a new Green Bond Basket within its…
(IN BRIEF) Last Friday, NMB Bank Plc celebrated the listing of its dual-currency sustainability bond,…
(IN BRIEF) CapMan Nordic Infrastructure II fund has reached its final closing at over €375…
(IN BRIEF) AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated…
(IN BRIEF) AstraZeneca's Truqap, in combination with Faslodex, has received a positive recommendation from the…
(IN BRIEF) Ørsted, a global leader in renewable energy, is divesting its French onshore operations…